FACT vs PYXS
Comparison between FACT II Acquisition Corp - Class A (FACT, Company) and Pyxis Oncology Inc (PYXS, Company).
FACT is from the Financials sector, while PYXS is from the Healthcare sector.
FACT vs PYXS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
FACT vs PYXS - Historical Returns
Returns include dividend reinvestment.
FACT vs PYXS - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | FACT | PYXS |
|---|---|---|
| 2026 | +2.50% | +226.09% |
| 2025 | +5.26% | -31.95% |
| 2024 | +0.20% | -24.27% |
| 2023 | N/A | +30.43% |
| 2022 | N/A | -88.28% |
| 2021 | N/A | -16.89% |
FACT vs PYXS Drawdown Comparison
The maximum drawdown for FACT was -0.76%, occurring on Jan 13, 2026. Recovery took 58 trading sessions.
The maximum drawdown for PYXS was -93.57%, occurring on Apr 8, 2025. This drawdown has not yet recovered.
The current FACT drawdown is -0.09%. The current PYXS drawdown is -72.51%.
| Rank | FACT | PYXS |
|---|---|---|
| #1 | -0.76% Jan 8, 2026 - Apr 2, 2026 | -93.57% Nov 4, 2021 - Apr 8, 2025 |
| #2 | -0.67% Oct 27, 2025 - Dec 31, 2025 | -12.95% Oct 8, 2021 - Oct 28, 2021 |
| #3 | -0.59% Apr 21, 2025 - May 12, 2025 | -1.05% Oct 29, 2021 - Nov 3, 2021 |
| #4 | -0.57% Aug 12, 2025 - Sep 30, 2025 | N/A |
| #5 | -0.56% May 28, 2026 - Jul 6, 2026 | N/A |
| #6 | -0.50% Apr 15, 2025 - Apr 21, 2025 | N/A |
| #7 | -0.49% May 23, 2025 - Jun 6, 2025 | N/A |
| #8 | -0.39% Jul 1, 2025 - Jul 28, 2025 | N/A |
| #9 | -0.30% Dec 20, 2024 - Dec 30, 2024 | N/A |
| #10 | -0.29% May 20, 2025 - May 23, 2025 | N/A |
| #11 | -0.29% Jul 28, 2025 - Aug 8, 2025 | N/A |
| #12 | -0.25% Feb 7, 2025 - Feb 24, 2025 | N/A |
| #13 | -0.25% Apr 3, 2025 - Apr 14, 2025 | N/A |
| #14 | -0.20% May 12, 2025 - May 14, 2025 | N/A |
| #15 | -0.19% Sep 30, 2025 - Oct 21, 2025 | N/A |
Correlation
Correlation between FACT and PYXS is 0.41 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks